Alembic Pharmaceuticals has secured final approval for its abbreviated new drug application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials from the US Food and Drug Administration (FDA). The product is the generic version of Roche’s Toradol Injection, 15 mg/mL, 30 mg/mL, and 60 […]
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has secured final approval for its analgesic drug Ketorolac Tromethamine Tablets USP, 10 mg from the US Food and Drug Administration (FDA). The approved product is a generic version of Toradol. Ketorolac Tromethamine Tablets are approved for their use in easing moderately severe pain, commonly after surgery. According […]
